600196.SS
600196.SS
CNE000000X38
SHANGHAI FOSUN PHARMACEUTICAL G
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 41.661.612.748 41.067.195.863
1.4%
Cost of Revenue 20.800.103.192 21.365.573.972
2.6%
Gross Profit 20.861.509.556 19.701.621.890
5.9%
17.715.355.560 16.498.479.846
7.4%
Operating Income 3.146.153.996 3.203.142.045
1.8%
Pretax Income 5.111.983.264 4.169.281.680
22.6%
Net Income Common Stockholders 3.370.561.563 2.769.886.631
21.7%
-- --
--
-- --
--
ende